Aridis Pharmaceuticals In...

OTC: ARDS · Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Apr 01, 2025, 9:51 AM

Aridis Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
4.88M 19.99M
Short-Term Investments
n/a n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
905K -1.38M
Receivables
1.24M 237K
Inventory
n/a -237K
Other Current Assets
2.17M 3.35M
Total Current Assets
11.63M 26.8M
Property-Plant & Equipment
2.15M 1.36M
Goodwill & Intangibles
17K 22K
Total Long-Term Assets
3.07M 2.31M
Total Assets
14.7M 26.8M
Account Payables
2.31M 5.24M
Deferred Revenue
20.17M 20.84M
Short-Term Debt
4.3M 696K
Other Current Liabilities
15K 110K
Total Current Liabilities
36.9M 33.35M
Long-Term Debt
n/a 5.28M
Other Long-Term Liabilities
n/a 363K
Total Long-Term Liabilities
2.03M 6.56M
Total Liabilities
38.93M 40.91M
Total Debt
6.13M 5.98M
Common Stock
3K 2K
Retained Earnings
-195.67M -165.29M
Comprehensive Income
5.05M n/a
Shareholders Equity
-24.23M -14.11M
Total Investments
n/a n/a